<qa>  What is the name of the subject who will be allowed to continue JS-001 administration?In the absence of confirmed disease progression and intolerable toxicities, subjects in the single dose cohorts and multiple dose cohorts will be allowed to continue JS-001 administration with the consent of the subject. 